Significance of serum VIP and PACAP in multiple sclerosis: an exploratory case-control study.

Al-Keilani, Maha S; Almomani, Basima A; Al-Sawalha, Nour A; Al Qawasmeh, Majdi; Jaradat, Saied A

Al-Keilani, Maha S; Almomani, Basima A; Al-Sawalha, Nour A; Al Qawasmeh, Majdi; Jaradat, Saied A.

Affiliation

Al-Keilani MS; College of Pharmacy, Department of Clinical Pharmacy, Jordan University of Science and Technology, P.O. Box 3030, Irbid, 22110, Jordan. mskeilani@just.edu.jo.
Almomani BA; College of Pharmacy, Department of Clinical Pharmacy, Jordan University of Science and Technology, P.O. Box 3030, Irbid, 22110, Jordan.
Al-Sawalha NA; College of Pharmacy, Department of Clinical Pharmacy, Jordan University of Science and Technology, P.O. Box 3030, Irbid, 22110, Jordan.
Al Qawasmeh M; College of Medicine, Department of Neurology, Jordan University of Science and Technology, P.O. Box 3030, Irbid, 22110, Jordan.
Jaradat SA; College of Science and Art, Department of Biotechnology and Genetic Engineering, Jordan University of Science and Technology, P.O. Box 3030, Irbid, 22110, Jordan.

Neurol Sci ; 43(4): 2621-2630, 2022 Apr.

Article de En | MEDLINE | ID: mdl-34698942

Sujet(s)
Mots clés

CIS; Multiple sclerosis; PACAP; Progressive; Relapsingremitting; VIP

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Peptide vasoactif intestinal / Polypeptide activateur de l'adénylcyclase hypophysaire / Sclérose en plaques Type d'étude: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Female / Humans / Male Langue: En Journal: Neurol Sci Sujet du journal: NEUROLOGIA Année: 2022 Type de document: Article Pays d'affiliation: Jordanie Pays de publication: Italie

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google